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Abstract
Introduction: There are approximately 7000 new cases of tuberculosis every year in the UK, the majority of which
are pulmonary. Approximately 5% affect the lymph nodes in immunocompetent patients. Scrofula is an old term
used to describe lymph nodes of the neck infected with tuberculosis
Case presentation: In the elderly population, growing neck lumps are always treated as red flags until a diagnosis
is confirmed. Here, the case of an 89-year-old Caucasian woman is presented. She was reluctant to seek medical
help as she feared the cause was sinister and did not want surgical intervention.
Conclusion: It is difficult to culture tuberculosis from superficial swabs, resulting in a high proportion of false
negative results. Where there is a high degree of clinical suspicion for tuberculosis, it is important to consider a
biopsy with culture. Patients over the age of 65 have waning immunity and are therefore a vulnerable group for
acute infections as well as the re-activation of indolent organisms. Post-splenectomy patients are at a major
disadvantage during sepsis and when a cellular immune response is required, such as when faced with a
Mycobacterium tuberculosis infection. Scrofula is treated with a similar regime as pulmonary tuberculosis and has a
near 100% success rate.
Introduction
In the elderly population, growing neck lumps are
always treated as red flags until a diagnosis is confirmed.
The case of an elderly patient presenting with neck
lumps is here described. She was reluctant to seek medi-
cal help as she feared the cause was sinister and did not
want surgical intervention. There are many laboratory
tests used to diagnose tuberculosis (TB) infection how-
ever we rely on a high level of clinical suspicion.
Scrofula is an old term for TB affecting the lymph
nodes of the neck, a more meaningful term is cervical
tuberculous lymphadenopathy. It is usually the result of
a primary infection of the lymph nodes with Mycobac-
terium tuberculosis. The bacteria can be spread by the
lymphatic system or blood. Therefore, it could originate
from a primary pulmonary focus. In adults, it is usually
M. tuberculosis and in children, nontuberculous myco-
bacteria [1].
Scrofuloderma results from the breakdown of skin
overlying a tuberculous focus, usually at a lymph node
but also where skin overlies infected bones or joints. In
the past, milk was frequently contaminated with M.
bovis that resulted in a high number of children present-
ing with scrofuloderma. The oral or tonsillar primary
lesion could progress to cervical adenitis which in turn
resulted in the formation of cold abscesses. Clinically,
these lesions are firm painless nodules that gradually
enlarge and suppurate, forming ulcers and sinus tracts
in overlying skin. Spontaneous healing can occur but
often takes years and is often accompanied by the for-
mation of hypertrophic scars. As in this case, the most
common presentation of scrofula is a painless, often
suppurative abscess that shows no signs of calor or
erythema unless there is a secondary infection. Patients
less frequently present with systemic signs such as
weight loss and night sweats [2].
In Europe, with the rapid decrease of TB in the sec-
ond half of the twentieth century, scrofula has become a
very rare disease. The marked decrease in prevalence
Correspondence: aaronniblock@doctors.net.uk
Royal Victoria Hospital, Medical Department, 274 Grosvenor Road, Belfast
BT12 6BA
Niblock Journal of Medical Case Reports 2011, 5:584
http://www.jmedicalcasereports.com/content/5/1/584 JOURNAL OF MEDICAL
CASE REPORTS
© 2011 Niblock; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.amongst the more economically developed countries
was due to the pasteurization of milk and the Bacillus
Calmette-Guérin vaccine. TB is still a major problem
across the less economically developed countries, and
therefore clinicians have a higher degree of suspicion
when assessing patients.
Every year in the UK, it is estimated that there are
7000 new cases of TB. According to a study carried out
in India, extrapulmonary TB constitutes about 15% to
20% of new TB cases in immunocompetent patients.
These extrapulmonary sites are demonstrated in
Figure 1. This can rise to over 50% in immunocompro-
mised patients, especially in patients positive for the
human immunodeficiency virus (HIV) [3].
Body response to infection with TB
TB is spread by droplets that are inhaled into the
respiratory tract, passing through the pharynx. It most
commonly affects the lungs although it is possible to
trigger a response in the tonsillar region. How the host’s
immune system responds to M. tuberculosis has a major
role in determining the clinical manifestations. Once the
organism has reached the alveoli it has four potential
fates [4]: the immune system may destroy the bacilli and
the patient gains immunity; the bacilli multiple and
cause disease, that is, pulmonary TB; the bacilli become
dormant and never cause disease; or the patient may
develop reactivation TB - active disease due to an exist-
ing impairment in the immune system through, for
example, HIV, malignancy or malnutrition.
During the primary infection with TB and during any
subsequent secondary active disease, the bacteria are
spread by blood or through the lymphatic system to any
part of the body. Usually the bacteria are destroyed by
the immune system; however, they may concentrate at a
particular site and lie dormant for decades before caus-
ing disease.
Case presentation
An 89-year-old Caucasian woman presented to our out-
patients clinic with a left-sided neck lump which she
had had for six months. It had started as a small pea-
s i z e dl u m pa n dd e v e l o p e di n t oa3c m×4c ms m o o t h ,
fixed mass (Figure 2). It had grown relatively slowly and
the woman has been otherwise healthy throughout. She
reported no pyrexia, dysphagia, weight loss, night sweats
or hoarseness. Accompanied by her niece, our patient
made it clear that, if it was malignant, she wanted it
treated conservatively.
A further history revealed that she had a three-year
history of recurrent neck swellings that progressed to
abscesses, continuously discharging and healing slowly.
On closer physical inspection, there was visible scar-
ring from a previous abscess approximately 5 cm infer-
i o rt ot h i sm a s so nh e rl e f ts i d e .A sc a nb es e e ni n
Figure 3 and Figure 4, on our patient’sr i g h ts i d et h e r e
was an old, slowly healing abscess that has been present
for over a year.
Our patient had always enjoyed good health, with the
only other significant past medical history being a
Figure 1 Pie Chart to compare the % of Pulmonary TB (PTB) to
Extra-Pulmonary TB (EPTB) in newly diagnosed cases. Column
graph demonstrates the breakdown of Extra Pulmonary sites of TB
infection in the 15-20%. Figure 2 Image to show left sided neck abscess.
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The abscesses were treated by her general practitioner
with recurrent antibiotics and frequent dressings. Pre-
vious swabs from the neck abscess, sent by her general
practitioner, did not grow the tuberculous organism.
Our patient agreed to have further investigations. A
chest X-ray and fine needle aspiration (FNA) were per-
formed. The chest X-ray showed chronic fibrotic
changes and no evidence of TB infection. The FNA con-
tained necrotic debris and foam cells; acute inflamma-
tory cells were not prominent and granulomata were
not seen. Ziehl-Neelsen staining was performed and no
acid-alcohol fast bacilli were seen. The features found
represented a partially treated skin abscess but the nega-
tive staining did not exclude the possibility of TB. Part
of the aspirate was submitted to microbiology for con-
ventional and TB culture.
The differential diagnosis included neoplasia, tertiary
syphilis, deep fungi (for example, sporotrichosis, actino-
mycosis) and chronic granulomatous disease.
Three weeks after submitting the aspirate to micro-
biology for culture, TB was confirmed. The infectious
disease team took over our patient’s care immediately.
Our patient underwent various tests, including liver
function tests, urea and electrolytes test, HIV screening
and visual acuity prior to commencing the anti-TB
regime.
Our patient was started on ethambutol 700 mg to be
taken in the morning, rifampicin 450 mg, isoniazid 300
mg, pyrazinamide 900 mg and pyridoxine 20 mg. Within
two months she showed a significant improvement, and
after four months there were visible scars only.
Discussion
The body’s initial immune response involves Type 1
CD4+ T lymphocytes and natural killer T lymphocytes
(NK cells) that secrete interferon-gamma. This acti-
vates macrophages to produce a variety of substances
that inhibit growth and kill mycobacteria. This is a
very simplified explanation; the process involves many
other aspects including suppression from interleukin
4-10, amplification by interleukin 12 and many cyto-
kines [5].
Re-infection is a rare event when immunity is intact,
however, over the past few decades it has been demon-
strated in patients with advanced HIV, with the use of
chemotherapy and disease-modifying antirheumatic
Figure 3 old slow to heal right sided neck abscess,
scrofuloderma skin changes.
Figure 4 image to show the contrast between the two abscess
at different stages, left sided is more recent whilst the right
has partially healed with the surrounding scrofuloderma skin
changes.
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that reduces the host immune response [6].
Aging is known to have detrimental effects on the
immune system and is referred to as immunosenes-
cence. It is a complex process that affects cell mediated
immunity [7]. As we age, we lose lymphoid tissue. T-cell
activation is reduced plus a larger percentage of acti-
vated T-cells responses start later and stop sooner. NK
cell activity is also reduced significantly. It has been sug-
gested that, as we age, the innate response prevails over
the adaptive response [8-10].
The immune response to TB greatly relies on T lym-
phocytes and NK cells and so the aging immune system
is much less capable of responding to M. tuberculosis.
The spleen is an important organ in the defense
against invading pathogens. It acts as a filtering system,
permitting phagocytosis of bacteria by cells in the reti-
culoendothelial system. The spleen is also an important
site capable of producing large quantities of antibodies,
which has proven vital in preventing and tackling sepsis.
Therefore, the major risk post-splenectomy is that of
overwhelming sepsis [11].
The humoral role of the spleen has been well docu-
mented and recent studies have shown the spleen to
have a significant role in cell mediated immunity. The
spleen is an important organ for the differentiation and
maturation of stem cells into immunocompetent B-cells.
B-cells were once mostly associated with the humoral
immune response. However, recent studies have shown
a variety of interactions of B-cells with the cellular
immune response, which is necessary against infection
by M. tuberculosis [12].
In the future, if a mass is suspected for TB, tissue
should be attained to help with the diagnosis. As in
this case, the initial Ziehl-Neelsen stain came back
negative, however the culture was positive. This is a
common problem and emphasizes the importance of a
high clinical suspicion. Having to repeat FNA is also
common, especially if the mass is long standing. Some
empirical antibiotics, such as macrolides, have been
shown to partly treat mycobacterium organisms, there-
fore reducing the likelihood of getting positive
cultures.
Treatment is similar to that for pulmonary disease,
which is with isoniazid, rifampicin, pyrazinamide and
ethambutol for two months followed by a longer course
of rifampicin and isoniazid. The length of time for treat-
ment has long been debated, with no firm consensus.
The duration depends on the patient, the response to
treatment, the risk of relapse and the site and tissue
involved. Where there is limited lymph node involve-
ment, treatment is usually continued for at least four
months. Surgery is usually not implicated. With ade-
quate treatment, clinical remission is practically 100%. It
is recommended that people in close contact, such as
family members, should undergo testing for TB.
There are numerous investigations to be taken prior
to initiating anti-TB treatment. These include a full
blood count, a urea and electrolytes test, uric acid analy-
sis, liver function tests, HIV screening, chest X-ray and
three sputum acid-fast bacillus smears (to ensure no
pulmonary involvement). Visual acuity and fields should
be documented prior to treatment.
For the first two months, a regime of four drugs is
used: isoniazid 5 mg/kg, rifampicin 10 mg/kg, pyrazina-
mide 20 mg/kg, ethambutol 25 mg/kg and pyridoxine
10 mg once daily.
Thereafter, a three-weekly regime can be used for a
following four or more months: isoniazid 10 mg/kg,
rifampicin 10 mg/kg and pyridoxine 10 mg once daily
[13]. Local infectious disease departments should be
contacted for advice and risk stratification.
Conclusion
Our patient and her family were convinced there was an
underlying malignant process and therefore she lived
with these recurrent lumps and abscesses for years,
undergoing daily dressings and multiple courses of anti-
biotics. She was very relieved to get a diagnosis of neck
lymph node TB and overwhelmed to learn that the
treatment basically has a 100% success rate. There is a
high false negative culture result from superficial swabs,
therefore a biopsy with culture should be considered if
there is a high degree of clinical suspicion.
It is important to realize that patients aged over 65
years have waning immunity and therefore are a vulner-
able group for infections as well as re-activation. Post-
splenectomy patients are at a major disadvantage in sep-
sis and also in cellular immunity, as in the required
response for M. tuberculosis infection.
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